PAA 2.94% 17.5¢ pharmaust limited

Ann: Appendix 4C - Quarterly Report & Brief Company Update, page-7

  1. 562 Posts.
    lightbulb Created with Sketch. 86
    I queried an officeholder on this exact point several months ago and the response was that Epichem is profitable. (actually I asked whether I could obtain a copy of the subsidiary's (Epichem) financial statements too but was declined on that front).

    My question to you - how do you arrive at conclusion that Epichem is not profitable?

    Epichem has a compound annual growth rate of 30% and international ISO accreditations are expected later this year which will boost demand even higher. I think it would be foolish to scale back this operation.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
17.5¢
Change
0.005(2.94%)
Mkt cap ! $82.69M
Open High Low Value Volume
17.5¢ 17.5¢ 17.0¢ $52.47K 300.6K

Buyers (Bids)

No. Vol. Price($)
12 567354 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 205056 4
View Market Depth
Last trade - 14.27pm 10/09/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.